RETRACTABLE TECHNOLOGIES INC
Retractable Technologies Inc (RVP) is a small‑cap medical‑device company focused on safety‑engineered syringes and sharps‑injury prevention products designed to reduce needlestick risks in healthcare and community settings. With a market capitalisation of roughly $31.7 million, it sits in the micro‑cap space where both upside and downside can be amplified by limited liquidity, narrow product lines and the pace of commercial adoption. Key things for investors to watch include product uptake among hospitals and pharmacies, regulatory approvals, distribution or licensing agreements, and the company’s cash position and execution against commercial plans. Micro‑cap healthcare firms can benefit from clear clinical demand but also face concentrated customer bases and strong competition. This summary is for general educational purposes only and is not personalised investment advice; investors should carry out their own research and consider suitability before investing, as values can rise and fall.
Stock Performance Snapshot
Financial Health
Retractable Technologies Inc is generating modest revenue and cash flow, but low profit margins may be a concern.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring RVP
At-Home Treatment Revolution | FDA Approval Impact
The FDA's approval of an injectable, at-home version of Eisai and Biogen's Alzheimer's drug signals a major shift in chronic disease management. This creates an investment opportunity in companies that develop advanced drug delivery systems and support at-home patient care.
Published: September 1, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Safety Syringe Focus
Products target needlestick prevention, a clear clinical need that can support demand, though adoption depends on budgets and procurement decisions.
Small Cap Volatility
Micro‑cap status can mean higher upside potential but also greater price swings and limited liquidity; due diligence is important.
Regulation and Uptake
Regulatory approvals and purchasing policies shape market access and revenue potential; changes can materially affect outcomes.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
